BNR (Burning Rock Biotech) Short-Term Capital Lease Obligation : $3.37 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Short-Term Capital Lease Obligation?

Burning Rock Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $3.37 Mil.

Burning Rock Biotech's quarterly Short-Term Capital Lease Obligation increased from Jun. 2024 ($3.71 Mil) to Sep. 2024 ($3.94 Mil) but then declined from Sep. 2024 ($3.94 Mil) to Dec. 2024 ($3.37 Mil).

Burning Rock Biotech's annual Short-Term Capital Lease Obligation declined from Dec. 2022 ($5.34 Mil) to Dec. 2023 ($1.21 Mil) but then increased from Dec. 2023 ($1.21 Mil) to Dec. 2024 ($3.37 Mil).

Burning Rock Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Burning Rock Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Short-Term Capital Lease Obligation Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.74

5.50

5.34

1.21

3.37

Burning Rock Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.21	1.53	3.71	3.94	3.37

Burning Rock Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Burning Rock Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

6BU0:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.